Iranian Journal of Radiology

Published by: Kowsar

Clinical Feasibility Assessment of T3 Sub-Stage in Rectal Cancer Using MRI

Tripathi Pratik 1 , 2 , Weifeng Guo 1 , 2 , Chun Yang 1 , 2 , Rai Bimal 3 and Mengsu Zeng 1 , 2 , *
Authors Information
1 Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
2 Shanghai Institute of Medical Imaging, Department of Medical Imaging, Shanghai Medical School, Fudan University, Shanghai, China
3 Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Article information
  • Iranian Journal of Radiology: April 2018, 15 (2); e16801
  • Published Online: March 10, 2018
  • Article Type: Research Article
  • Received: March 16, 2017
  • Revised: January 21, 2018
  • Accepted: January 29, 2018
  • DOI: 10.5812/iranjradiol.16801

To Cite: Pratik T, Guo W, Yang C, Bimal R, Zeng M. Clinical Feasibility Assessment of T3 Sub-Stage in Rectal Cancer Using MRI, Iran J Radiol. 2018 ; 15(2):e16801. doi: 10.5812/iranjradiol.16801.

Copyright © 2018, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Kang H, O'Connell JB, Leonardi MJ, Maggard MA, McGory ML, Ko CY. Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis. 2007;22(2):183-9. doi: 10.1007/s00384-006-0145-2. [PubMed: 16845516].
  • 2. Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol. 2008;191(6):1827-35. doi: 10.2214/AJR.08.1004. [PubMed: 19020255].
  • 3. Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19(7):2212-23. doi: 10.1245/s10434-011-2210-5. [PubMed: 22271205].
  • 4. Beets-Tan RG. MRI in rectal cancer: the T stage and circumferential resection margin. Colorectal Dis. 2003;5(5):392-5. doi: 10.1046/j.1463-1318.2003.00518.x. [PubMed: 12925068].
  • 5. Rao SX, Zeng MS, Xu JM, Qin XY, Chen CZ, Li RC, et al. Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention. World J Gastroenterol. 2007;13(30):4141-6. doi: 10.3748/wjg.v13.i30.4141. [PubMed: 17696238].
  • 6. Akagi Y, Shirouzu K, Fujita S, Ueno H, Takii Y, Komori K, et al. Predicting oncologic outcomes by stratifying mesorectal extension in patients with pT3 rectal cancer: a Japanese multi-institutional study. Int J Cancer. 2012;131(5):1220-7. doi: 10.1002/ijc.27315. [PubMed: 22025276].
  • 7. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis. 2001;16(5):298-304. doi: 10.1007/s003840100309. [PubMed: 11686527].
  • 8. Shin R, Jeong SY, Yoo HY, Park KJ, Heo SC, Kang GH, et al. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum. 2012;55(12):1220-8. doi: 10.1097/DCR.0b013e31826fea6a. [PubMed: 23135579].
  • 9. Bori R, Sejben I, Svebis M, Vajda K, Marko L, Pajkos G, et al. Heterogeneity of pT3 colorectal carcinomas according to the depth of invasion. Pathol Oncol Res. 2009;15(3):527-32. doi: 10.1007/s12253-009-9149-x. [PubMed: 19172413].
  • 10. Miyoshi M, Ueno H, Hashiguchi Y, Mochizuki H, Talbot IC. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg. 2006;243(4):492-8. doi: 10.1097/01.sla.0000205627.05769.08. [PubMed: 16552200].
  • 11. Mercury Study Group . Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132-9. doi: 10.1148/radiol.2431051825. [PubMed: 17329685].
  • 12. Gowdra Halappa V, Corona Villalobos CP, Bonekamp S, Gearhart SL, Efron J, Herman J, et al. Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol. 2012;199(1):W35-42. doi: 10.2214/AJR.11.8134. [PubMed: 22733930].
  • 13. Spiegle G, Leon-Carlyle M, Schmocker S, Fruitman M, Milot L, Gagliardi AR, et al. Development of a synoptic MRI report for primary rectal cancer. Implement Sci. 2009;4:79. doi: 10.1186/1748-5908-4-79. [PubMed: 19954526].
  • 14. Shirouzu K, Akagi Y, Fujita S, Ueno H, Takii Y, Komori K, et al. Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study. Ann Surg. 2011;253(4):704-10. doi: 10.1097/SLA.0b013e3182119331. [PubMed: 21475010].
  • 15. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420-8. doi: 10.1037/0033-2909.86.2.420. [PubMed: 18839484].
  • 16. Hallgren KA. Computing Inter-Rater Reliability for Observational Data: An Overview and Tutorial. Tutor Quant Methods Psychol. 2012;8(1):23-34. doi: 10.20982/tqmp.08.1.p023. [PubMed: 22833776].
  • 17. Egner JR. AJCC cancer staging manual. 304. JAMA: The Journal of the American Medical Association; 2010. 1726 p.
  • 18. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, et al. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012;32(2):389-409. doi: 10.1148/rg.322115122. [PubMed: 22411939].
  • 19. Pedersen BG, Moran B, Brown G, Blomqvist L, Fenger-Gron M, Laurberg S. Reproducibility of depth of extramural tumor spread and distance to circumferential resection margin at rectal MRI: enhancement of clinical guidelines for neoadjuvant therapy. AJR Am J Roentgenol. 2011;197(6):1360-6. doi: 10.2214/AJR.11.6508. [PubMed: 22109290].
  • 20. Cho SH, Kim SH, Bae JH, Jang YJ, Kim HJ, Lee D, et al. Prognostic stratification by extramural depth of tumor invasion of primary rectal cancer based on the Radiological Society of North America proposal. AJR Am J Roentgenol. 2014;202(6):1238-44. doi: 10.2214/AJR.13.11311. [PubMed: 24848820].
  • 21. Glimelius B, Pahlman L, Cervantes A, Esmo Guidelines Working Group . Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v82-6. doi: 10.1093/annonc/mdq170. [PubMed: 20555109].
  • 22. Benson A3, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, et al. Rectal cancer. J Natl Compr Canc Netw. 2012;10(12):1528-64. [PubMed: 23221790].
  • 23. Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711-9. doi: 10.1097/SLA.0b013e31820b8d52. [PubMed: 21475011].
  • 24. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23(10):2479-516. doi: 10.1093/annonc/mds236. [PubMed: 23012255].
  • 25. Merkel S, Weber K, Schellerer V, Gohl J, Fietkau R, Agaimy A, et al. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria. Br J Surg. 2014;101(5):566-72. doi: 10.1002/bjs.9419. [PubMed: 24477831].
  • 26. Zinicola R, Pedrazzi G, Haboubi N, Nicholls RJ. The degree of extramural spread of T3 rectal cancer: an appeal to the American Joint Committee on Cancer. Colorectal Dis. 2017;19(1):8-15. doi: 10.1111/codi.13565. [PubMed: 27883254].
  • 27. Benson A3, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, et al. Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015;13(6):719-28. quiz 728. doi: 10.6004/jnccn.2015.0087. [PubMed: 26085388].
  • 28. Breugom AJ, Vermeer TA, van den Broek CB, Vuong T, Bastiaannet E, Azoulay L, et al. Effect of preoperative treatment strategies on the outcome of patients with clinical T3, non-metastasized rectal cancer: A comparison between Dutch and Canadian expert centers. Eur J Surg Oncol. 2015;41(8):1039-44. doi: 10.1016/j.ejso.2015.05.002. [PubMed: 26059312].
  • 29. Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20(3):817-25. doi: 10.1200/JCO.2002.20.3.817. [PubMed: 11821466].
  • 30. Lange MM, Marijnen CA, Maas CP, Putter H, Rutten HJ, Stiggelbout AM, et al. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer. 2009;45(9):1578-88. doi: 10.1016/j.ejca.2008.12.014. [PubMed: 19147343].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments